Growing community of inventors

Paris, France

Gilles Courtois

Average Co-Inventor Count = 5.65

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Gilles CourtoisAlain Israel (4 patents)Gilles CourtoisShoji Yamaoka (4 patents)Gilles CourtoisFrancois Traincard (3 patents)Gilles CourtoisFabrice Agou (3 patents)Gilles CourtoisMichel Veron (2 patents)Gilles CourtoisYves-Marie Coic (1 patent)Gilles CourtoisMichel Vernon (1 patent)Gilles CourtoisRobert Weil (1 patent)Gilles CourtoisYves-Marie Coiec (0 patent)Gilles CourtoisFrançois Traincard (0 patent)Gilles CourtoisYves-Marie COÏC (0 patent)Gilles CourtoisGilles Courtois (4 patents)Alain IsraelAlain Israel (5 patents)Shoji YamaokaShoji Yamaoka (4 patents)Francois TraincardFrancois Traincard (9 patents)Fabrice AgouFabrice Agou (8 patents)Michel VeronMichel Veron (5 patents)Yves-Marie CoicYves-Marie Coic (7 patents)Michel VernonMichel Vernon (1 patent)Robert WeilRobert Weil (1 patent)Yves-Marie CoiecYves-Marie Coiec (0 patent)François TraincardFrançois Traincard (0 patent)Yves-Marie COÏCYves-Marie COÏC (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Institut Pasteur (4 from 869 patents)

2. Centre National De La Recherche Scientifique (1 from 5,069 patents)

3. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)

4. Centre National De La Recherche Scientifique-cnrs (65 patents)

5. Inserm (0 patent)


4 patents:

1. 8790883 - Methods of identifying NF-κB inhibitors

2. 7700553 - Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization

3. 7390872 - NF-κB peptides designed to disrupt NEMO oligomerization

4. 6680366 - Nucleotide sequence encoding a modulator of NF-&kgr;B

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…